Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | P5 - Poster Session 5

Sunday 04/03/22
11:45 AM - 12:45 PM PDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Practice, Policy, and Ethics, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology
0.00 CME credit

Program Materials Program Evaluations

Event Timeline
11:45 AM - 12:45 PM PDT Abstract 9-001 - Serial Longitudinal EEG as a Biomarker in Autoimmune Encephalitis: A Retrospective Cohort Analysis
Cameron Mohammadi, MD
11:45 AM - 12:45 PM PDT Abstract 9-002 - Residual Symptoms and Long-term Outcomes after All-Cause Autoimmune Encephalitis
Hesham Ahmed Abboud, MD
11:45 AM - 12:45 PM PDT Abstract 9-003 - Validation of Clinical, Radiographic, and Laboratory Screening Criteria for Autoimmune Encephalitis
Daniela Raffaela Galluzzo, MD
11:45 AM - 12:45 PM PDT Abstract 9-004 - The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis
Gregory S. Day, MD, MSc, FAAN
11:45 AM - 12:45 PM PDT Abstract 9-006 - Autoimmune encephalitis in a tertiary hospital in the Philippines
Nikolai Gil Diwa Reyes, MD
11:45 AM - 12:45 PM PDT Abstract 9-007 - Balint Syndrome as an Atypical Presentation of Paraneoplastic Anti-NMDA Receptor Encephalitis: A Case Report and Review of the Literature
Neda Sattarnezhad, MD
11:45 AM - 12:45 PM PDT Abstract 15-001 - Arachnoiditis After Epidural Blood Patch to Treat Low Pressure Headache : A Case Study
Shawna Huckell
11:45 AM - 12:45 PM PDT Abstract 15-002 - Migraine-Associated Gene Expression in Vascular Cell Types
Luke Skyler Vest
11:45 AM - 12:45 PM PDT Abstract 15-003 - Perfusion Imaging in Acute Hemiplegic Migraine
Kyle R. Marden, MD
11:45 AM - 12:45 PM PDT Abstract 15-004 - Patient Satisfaction Is Associated With Positive Communications With Health Care Professionals: Interim Results From a Survey of an Online Migraine Community
Edward Kim, MD
11:45 AM - 12:45 PM PDT Abstract 15-005 - Alcohol as a risk factor for migraine attacks. Results from a large prospective cohort study in English-speaking countries.
Noah Rosen, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 15-006 - Migraine and Adverse Pregnancy Outcomes: the nuMoM2b Study
Gular Mammadli, MD
11:45 AM - 12:45 PM PDT Abstract 3-001 - Cerezen (Renew™ NCP-5) for the Treatment of Mild Cognitive Impairment due to Alzheimer’s Disease or Mild Dementia of the Alzheimer’s Type in Subjects With Type 2 Diabetes
Patrick M. Moriarty, MD
11:45 AM - 12:45 PM PDT Abstract 3-002 - A Phase 1 Study of AL003 in Healthy Volunteers and Participants with Alzheimer’s disease
Daniel Maslyar, MD
11:45 AM - 12:45 PM PDT Abstract 3-003 - A First-in-Human Study of the Anti-Sortilin Antibody AL101
Michael Ward
11:45 AM - 12:45 PM PDT Abstract 3-004 - A Phase 1 Study of AL002 in Healthy Volunteers
Michael Ward
11:45 AM - 12:45 PM PDT Abstract 3-005 - A Phase 2 Study of AL001 in Frontotemporal Dementia Patients Carrying a Granulin Mutation
Julie Huang, PhD
11:45 AM - 12:45 PM PDT Abstract 12-001 - Safety and Efficacy of Evobrutinib, a Bruton’s Tyrosine Kinase Inhibitor in Relapsing Multiple Sclerosis Over 2.5 Years of The Open-Label Extension to a Phase II Trial
Xavier Montalban, MD, PhD, FAAN
11:45 AM - 12:45 PM PDT Abstract 12-002 - Analyses of the Effect of Baseline Age on the Efficacy and Safety of Siponimod in Patients with Active Secondary Progressive Multiple Sclerosis from the Phase 3 EXPAND Study
Le Hua, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 12-003 - Efficacy and Safety of Ocrelizumab in Patients With RRMS With Suboptimal Response to Prior Disease-Modifying Therapies: 3-Year Data From CASTING and LIBERTO (LIBERTO 1-Year Interim Results)
Patrick Vermersch
11:45 AM - 12:45 PM PDT Abstract 12-004 - Long-term Efficacy of Ofatumumab in Patients With Relapsing Multiple Sclerosis
Ludwig Kappos, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 12-005 - Impact of ozanimod treatment on cortical grey matter volume: up to 5 years’ experience in phase 3 and extension trials
Chahin Pachai
11:45 AM - 12:45 PM PDT Abstract 12-006 - Cognitive Processing Speed Predicts Disease Progression in Secondary Progressive Multiple Sclerosis: Post Hoc Analysis from the EXPAND Study
Daniela Piani Meier
11:45 AM - 12:45 PM PDT Abstract 12-007 - Vaginal Estriol as a potential adjunctive therapy for MS remyelination
Mirla L. Avila, MD
11:45 AM - 12:45 PM PDT Abstract 12-008 - Effect of Ponesimod Compared With Teriflunomide on Treatment With Concomitant Corticosteroids for Relapse in Patients with Relapsing Forms of Multiple Sclerosis
Camilo Obando
11:45 AM - 12:45 PM PDT Abstract 12-009 - Disability Improvements With Ublituximab in Relapsing Multiple Sclerosis (RMS): Expanded Disability Status Scale (EDSS), 9-Hole Peg Test (9-HPT), and Timed 25-Foot Walk (T25FW) Evaluations From the Phase 3 ULTIMATE I and II Studies
Bruce A. C. Cree, MD, PhD, MCR, FAAN
11:45 AM - 12:45 PM PDT Abstract 12-010 - Five Years Analysis of anti-Glatiramer Acetate (GA) Antibodies in Patients with Relapsing Remitting Multiple Sclerosis Treated with GA Depot
Ehud Marom
11:45 AM - 12:45 PM PDT Abstract 12-011 - Multi-center, Randomized, Double-blinded Assessment of TERIFLUNOMIDE (Aubagio®) in Extending the Time to the First Attack in Radiologically Isolated Syndrome: Baseline Characteristics of the TERIS Study.
Christine Lebrun Frenay, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 6-001 - Physical Activity Moderates the Association Between White Matter Hyperintensity Burden and Cognitive Change
Suhang Song, PhD
11:45 AM - 12:45 PM PDT Abstract 6-002 - Survival analysis of patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): data from a systematic literature review of published case studies
Spyridon Papapetropoulos, MD, PhD
11:45 AM - 12:45 PM PDT Abstract 6-003 - COVID-19 Outcomes of 10,881 patients: Retrospective study Of Neurological symptoms and Associated manifestations (Philippine CORONA Study)
Adrian Isidoro Espiritu, MD
11:45 AM - 12:45 PM PDT Abstract 6-005 - Head Injury and All-Cause Mortality in Community-Dwelling Adults
Holly Elser, MD, PhD
11:45 AM - 12:45 PM PDT Abstract 7-001 - Efficacy of Everolimus for Tuberous Sclerosis Complex: A Systematic Review and Meta-analysis.
Fatma Mohamed Sayed
11:45 AM - 12:45 PM PDT Abstract 7-002 - A Rare MED13 Variant as the Potential Cause of Early Onset Cognitive Decline and Brain Iron Accumulation: A Case Report
Kaancan Deniz, MD
11:45 AM - 12:45 PM PDT Abstract 7-003 - Multifaceted presentation of a rare mitochondrial syndrome- HAREL-YOON SYNDROME - Story of 3 siblings
Muralikrishna Konda, MD, MBBS, MRCP
11:45 AM - 12:45 PM PDT Abstract 7-005 - Gene Expression Analysis of CCL2, MOBP and OPALIN in Major Depressive Disorder and Suicidality
Rui Tang
11:45 AM - 12:45 PM PDT Abstract 7-006 - A New Adult Neurodevelopmental Disabilities Clinic: Description of Population and Yield of Genetic Testing in the First Year
Moriah Mabry
11:45 AM - 12:45 PM PDT Abstract 1-001 - A Comparison of Telehealth and In-Person Visits in Ambulatory Neurology: What are the factors that patients consider when selecting future visit type?
Carly Jo Olszewski
11:45 AM - 12:45 PM PDT Abstract 1-002 - Evaluating Outcomes in Parkinson’s Disease Patients Following COVID-19 Interventions
Ari Vandersluis, DO
11:45 AM - 12:45 PM PDT Abstract 1-003 - From Distal to Proximal: Challenges Against Concordant Care for Patients with Neurological Disability
Margo A. Peyton, MD
11:45 AM - 12:45 PM PDT Abstract 10-001 - Hyperintense acute reperfusion marker (HARM) due to status epilepticus- A potential imaging pitfall'
Mustafa Al-Chalabi, DO
11:45 AM - 12:45 PM PDT Abstract 10-002 - Focal Seizures with Ictal Bradycardia from Right Insular Lesion in Tuberous Sclerosis: A Rare Case
Alok Dabi, MD, MBBS
11:45 AM - 12:45 PM PDT Abstract 10-003 - A novel customized representation of source space in epilepsy pre-surgical evaluation
Marcus Ng, MD
11:45 AM - 12:45 PM PDT Abstract 10-004 - Long-term seizure and functional outcome following occipital or ‘occipital-plus’ resection for refractory epilepsy in children
Elham Abushanab, MD
11:45 AM - 12:45 PM PDT Abstract 10-005 - Infantile Spasms in Cardiofaciocutaneous Syndrome: Associations with Genotype, Phenotype and Treatment Response
Dante James Rogers
11:45 AM - 12:45 PM PDT Abstract 10-007 - Cognitive Outcomes Following Pediatric Epilepsy Surgery
Navkiranjot Kaur
11:45 AM - 12:45 PM PDT Abstract 4-001 - Varicella Zoster Meningitis Presenting as Unilateral Vocal Cord Paralysis
Omar Muhsin Ali Al-Janabi, MD, PhD, MS
11:45 AM - 12:45 PM PDT Abstract 4-002 - West Nile Myelitis Disguised as Severe Compressive Myelopathy
Elizabeth Anderson, MD
11:45 AM - 12:45 PM PDT Abstract 4-003 - Clinical Characteristics of 11 Cases with Visual Impairment After Herpes Virus Infection
Jingxiao Zhang
11:45 AM - 12:45 PM PDT Abstract 4-004 - Perpetuating PML- Alcohol Induced Lymphopenia causing JC virus Reactivation
Mikul Minesh Bhikha
11:45 AM - 12:45 PM PDT Abstract 4-005 - Concurrent Olaparib and Temozolomide for Recurrent Glioma
Lauren Rhea Schaff, MD
11:45 AM - 12:45 PM PDT Abstract 4-006 - A multicenter observational study of Cs-131 seeds embedded in a collagen carrier tile in intracranial brain neoplasms – trial in progress
Erin M. Dunbar, MD
11:45 AM - 12:45 PM PDT Abstract 4-007 - BRAFV600E-mutant glioblastoma responds to combination BRAF/MEK inhibition with encorafenib and binimetinib
Elizabeth Coffee, MD
11:45 AM - 12:45 PM PDT Abstract 13-001 - Microglial IL-1RA ameliorates brain damage after ischemic stroke via inhibiting astrocyte-derived CXCL1
Xiaoyan Huang
11:45 AM - 12:45 PM PDT Abstract 13-002 - Immunoreactivity and A New Staining Method of MCT-1 Located in Endothelial Cells of Cerebral Vessels of Human Brain in Distinguishing Cerebral Venules from Arterioles
Yuan Cao
11:45 AM - 12:45 PM PDT Abstract 13-003 - Analysis of Protein Networks Associated with Hemorrhagic Conversion In Emergent Large Vessel Occlusion Patients Undergoing Mechanical Thrombectomy
Madison Sands
11:45 AM - 12:45 PM PDT Abstract 13-004 - Validating Existing Stroke Scales for Acute Identification of Cerebrovascular Events in an Inpatient Setting
Adriana Naomi Sari, MD
11:45 AM - 12:45 PM PDT Abstract 13-005 - Identifying Delays Associated with Door-to-Device Time for Potential Large Vessel Occlucion Thrombectomy Patients in the Emergency Department
Anirudh Sreekrishnan
11:45 AM - 12:45 PM PDT Abstract 13-006 - Acute stroke reperfusion therapies in patients with Posterior Reversible Encephalopathy Syndrome
Monica Sarkar, MD
11:45 AM - 12:45 PM PDT Abstract 13-007 - Stent Retrievers Utilization in Endovascular treatment of Cerebral Venous Sinus Thrombosis
Ch Hassan Ali, MD, MBBS
11:45 AM - 12:45 PM PDT Abstract 13-008 - Risk of Distal Embolization in Large Vessel Occlusion Strokes Treated with Tenecteplase
Siddhart Kumar Mehta, MD
11:45 AM - 12:45 PM PDT Abstract 5-001 - Patient Preferences for Deep Brain Stimulation Products in Parkinson's Disease: What Really Matters to Them?
Michelle Fullard, MD
11:45 AM - 12:45 PM PDT Abstract 5-002 - Impact of pre-existing small vessel disease on Motor Outcomes after Deep Brain Stimulation in Parkinson’s Disease
Heather Kristin Martin, MD
11:45 AM - 12:45 PM PDT Abstract 5-004 - Subthalamic tremor related oscillatory neuron plays a role in the generation of Parkinson's tremor
Ping Zhuang, PhD
11:45 AM - 12:45 PM PDT Abstract 5-005 - Algorithm-Guided Deep Brain Stimulation Programming Using Automated Motion Sensor-Based Functional Mapping Improves Programming Efficiency
Aaron Hadley
11:45 AM - 12:45 PM PDT Abstract 5-006 - Programming Time and the Use of a Visualization Tool for DBS Programming of a Multiple-Source, Constant-Current System
Jason Lamar Aldred, MD, FAAN
11:45 AM - 12:45 PM PDT Abstract 5-007 - Severity of Depressive and Motor Symptoms Impacts Quality of Life in Parkinson's Disease Patients of High Socioeconomic Status
Brianne Lacy, MD
11:45 AM - 12:45 PM PDT Abstract 5-008 - Real-world digital driving profiles in PD index motor and non-motor clinical symptom severity
Jun Ha Chang, PhD
11:45 AM - 12:45 PM PDT Abstract 2-001 - Neurological findings in sickle cell disease patients without a history of neurological insult: prevalence, risk factors and practice implications
Ahmed Moh'd Yassin, MD
11:45 AM - 12:45 PM PDT Abstract 2-002 - Clover-Leaf Curling Recovery in Functional Tongue Weakness
Michael Patrick Harlan Stanley, MD
11:45 AM - 12:45 PM PDT Abstract 2-003 - A Clinical Decision Rule Predicting Outcomes of Emergency Department Patients with Altered Mental Status
Tyrell Jonathan Simkins, DO
11:45 AM - 12:45 PM PDT Abstract 2-004 - Psychotherapeutic approach for the treatment of generalized anxiety disorder (GAD) improves outcome when delivered under specific (narrow band) green light condition.
Rami Burstein, PhD
11:45 AM - 12:45 PM PDT Abstract 2-005 - Gender and decistion making in Neurology, an Argentinian study.
Celica Ysrraelit
11:45 AM - 12:45 PM PDT Abstract 11-001 - Genetic Testing Analysis in Patients with Neuromuscular Disorders: A Single Health System Experience
Madelyn Kay Smiley
11:45 AM - 12:45 PM PDT Abstract 11-002 - Dermal Nerve Bundles Offer a Comprehensive, Accessible, Cutaneous Nerve Analysis
Kendall Nichols, MD
11:45 AM - 12:45 PM PDT Abstract 11-003 - Refining Compound Muscle Action Potential as a Translational Biomarker of Neuromuscular Integrity
Sindhuja Ayyagari
11:45 AM - 12:45 PM PDT Abstract 11-004 - Does High Resolution Ultrasound Guided Femoral Nerve Conduction Study Makes a Difference When Compared To Conventional Technique?
Abhinay Kumar Gattu, Jr.
11:45 AM - 12:45 PM PDT Abstract 11-005 - Value of Diaphragm Electromyography and Phrenic Nerve Conduction Studies in Suspected Diaphragm Paresis
Divya Rahul Shah, MBBS
11:45 AM - 12:45 PM PDT Abstract 11-006 - Electrodiagnostic Findings in Covid patients: A single center experience
Sajid Hameed Shaikh, MBBS, FCPS
11:45 AM - 12:45 PM PDT Abstract 11-007 - A pilot study of neuromuscular ultrasound as a biomarker for spinal-bulbar muscular atrophy
Abdullah Zahi Alqahtani, MD
11:45 AM - 12:45 PM PDT Abstract 11-008 - Quantitative muscle strength changes in adults with Spinal Muscular Atrophy receiving Nusinersen
Dana McDonnell, Other
11:45 AM - 12:45 PM PDT Abstract 11-009 - Real-World Data of Nusinersen in Adults with Spinal Muscular Atrophy: A Single Center Experience
Doruk Arslan, MD
11:45 AM - 12:45 PM PDT Abstract 11-010 - LOTS in the Needle Examination
Zara Abigail Togher, MB BCh BAO
Faculty Disclosures
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celgene. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has stock in NeuroRx.
Jeffrey Alan Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
John W. Day, MD, PhD Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Affinia Therapeutics. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Audentes. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Cytokinetics. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Kenneth H. Fischbeck, MD, FAAN Dr. Fischbeck has received research support from NINDS/NIH. Dr. Fischbeck has received intellectual property interests from a discovery or technology relating to health care. Dr. Fischbeck has a non-compensated relationship as a Scientific Review Board member with Kennedy's Disease Association that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Council member with Association Francaise contre les Myopathies that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Independent Review Committee member with Target ALS that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member, Musculoskeletal Diseases with Novartis that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Senior Clinical Consultant with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Committee member with Stanford GNE myopathy program that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Hereditary Disease Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Packard Center for ALS Research that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Huntington's Disease Society of America that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a TACT review panel member with TREAT-NMD that is relevant to AAN interests or activities.
Mark Hallett, MD, FAAN Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a President, Past-president with International Federation of Clinical Neurophysiology that is relevant to AAN interests or activities. Dr. Hallett has a non-compensated relationship as a President, Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Stephen L. Hauser, MD Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Fred D. Lublin, MD, FAAN Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Matthew Rizzo, MD, FAAN The institution of Dr. Rizzo has received research support from NIH. Dr. Rizzo has a non-compensated relationship as a Chair with ABC that is relevant to AAN interests or activities.
Lawrence Steinman, MD, FAAN Dr. Steinman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for 180 Life Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BioAtla. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pasithea. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atreca. Dr. Steinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Academy of Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Gibson Dunn. The institution of Dr. Steinman has received research support from Roche. The institution of Dr. Steinman has received research support from Novartis. Dr. Steinman has received intellectual property interests from a discovery or technology relating to health care.
Yaakov Stern, PhD Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
James C. Torner, PhD The institution of Dr. Torner has received research support from NIH.
John E. Trusheim, MD An immediate family member of Dr. Trusheim has received personal compensation for serving as an employee of Roche/Genentech. An immediate family member of Dr. Trusheim has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. An immediate family member of Dr. Trusheim has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Uniqure. An immediate family member of Dr. Trusheim has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. An immediate family member of Dr. Trusheim has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. An immediate family member of Dr. Trusheim has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Trusheim has received stock or an ownership interest from Fresca.
Jerry S. Wolinsky, MD, FAAN Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Daniel R. Wynn, MD Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to AAN interests or activities.
Ludwig Kappos, MD, FAAN The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care.
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Pierre Clavelou, MD,PhD Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Joab Chapman, MD, PhD Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk Serono. The institution of Dr. Chapman has received research support from Ministry Of Industry.
Edward J. Fox, MD, PhD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Ariel L. Miller, MD, PhD Dr. Miller has nothing to disclose.
Ramon R. Diaz-Arrastia, MD, PhD, FAAN Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ischemix, Inc. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pinteon Therapeutics. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from NovaSignal . Dr. Diaz-Arrastia has received stock or an ownership interest from Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Leonard Verhagen Metman, MD, PhD Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Richard B. Dewey, Jr., MD, FAAN Dr. Dewey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Dewey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Dewey has received research support from NINDS.
Ersin Tan, MD Dr. Tan has nothing to disclose.
Dimitrios Karussis, MD, PhD Prof. Karussis has nothing to disclose.
Rana Karabudak, MD Dr. Karabudak has nothing to disclose.
J. Robinson Singleton, MD Dr. Singleton has received research support from NIH.
Merit E. Cudkowicz, MD, MSC, FAAN Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for denali. The institution of Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for wave. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurosense. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for Arrowhead. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eledon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for roche. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . An immediate family member of Dr. Cudkowicz has stock in Sqz. The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSA . The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. Dr. Cudkowicz has received publishing royalties from a publication relating to health care.
Aksel Siva, MD Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Ron E. Milo, MD, FAAN Dr. Milo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck KGaA . Dr. Milo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Milo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brystol-Myers-Squibb . Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neopharm. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brystol-Myers-Squibb.
Steven Vernino, MD, PhD, FAAN Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Grifols. The institution of Dr. Vernino has received research support from Dysautonomia International. The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. Dr. Vernino has received personal compensation in the range of $10,000-$49,999 for serving as a Content Expert Consultant with Office of Inspector General for Medicare. Dr. Vernino has a non-compensated relationship as a Board of Directors with American Autonomic Society that is relevant to AAN interests or activities.
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Anne T. Berg, PhD Dr. Berg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Berg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded. Dr. Berg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biomarin. The institution of Dr. Berg has received research support from FamilieSCN2A Foundation.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen/Actelion. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech. The institution of Dr. Bar-Or has received research support from Merck/EMD Serono.
Robert K. Shin, MD, FAAN Dr. Shin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Shin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Shin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Shin has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shin has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Celgene. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Shin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mallinckrodt.
Arnon Karni, MD, PhD Prof. Karni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neopharm. Prof. Karni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Prof. Karni has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Israeli Court. The institution of Prof. Karni has received research support from Medison. The institution of Prof. Karni has received research support from Sanofi. The institution of Prof. Karni has received research support from Novartis. The institution of Prof. Karni has received research support from Roche.
Sibyl E. Wray, MD Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Scott M. Friedenberg, MD, FAAN Dr. Friedenberg has received research support from AMA. Dr. Friedenberg has received research support from Geisinger Medical Center.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche.
Daniel Pelletier, MD Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Ping Zhuang, PhD Dr. Zhuang has nothing to disclose.
Pierre Labauge, MD Dr. Labauge has nothing to disclose.
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japanese Tobacco. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aurinia Pharmaceuticals. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Oxford Health Policy Forum. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Peervoice. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bristows .
Goeril Karlsson, PhD Dr. Karlsson has received personal compensation for serving as an employee of Novartis.
Robert J. Fox, MD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for INmune Bio. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lily. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
James K. Sheffield, MD Dr. Sheffield has received personal compensation for serving as an employee of BMS.
Fredric A. Gorin, MD, PhD The institution of Dr. Gorin has received research support from NIH. The institution of Dr. Gorin has received research support from UC Davis School of Veterinary Medicine .
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique.
Shlomo Flechter, MD, FAAN Dr. Flechter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Flechter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma.
Tobias Kurth, MD, ScD Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TotalEnergies. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly & Company. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. The institution of Dr. Kurth has received research support from German Joint Committee. The institution of Dr. Kurth has received research support from Ministry of Health.
Deepak K. Lachhwani, MD, FAAN The institution of Dr. Lachhwani has received research support from ICON Clinical Research LLC.
Michael S. Okun, MD, FAAN Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Craig Nolan, MD Dr. Nolan has nothing to disclose.
Elia Margarita Pestana Knight, MD Dr. Pestana Knight has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Pestana Knight has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus Pharmaceuticals.
Ehud Marom Mr. Marom has received personal compensation for serving as an employee of Mapi Pharma. Mr. Marom has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Mapi Pharma. Mr. Marom has stock in Mapi Pharma. Mr. Marom has received intellectual property interests from a discovery or technology relating to health care.
Jagarlapudi Murali Krishna Murthy, MD, FAAN Dr. Murthy has nothing to disclose.
Spyridon Papapetropoulos, MD, PhD Dr. Papapetropoulos has received personal compensation for serving as an employee of Vigil Neuroscience . Dr. Papapetropoulos has received personal compensation for serving as an employee of Bionomics Ltd. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Lipocine Inc. Dr. Papapetropoulos has stock in Vigil Neuroscience. Dr. Papapetropoulos has stock in Lipocine. Dr. Papapetropoulos has stock in Bionomics Ltd.
Orhun H. Kantarci, MD Dr. Kantarci has nothing to disclose.
Ralph H. B. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Benedict has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brystal Mier Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Benedict has received research support from Genzyme. The institution of Dr. Benedict has received research support from Biogen. The institution of Dr. Benedict has received research support from Bristol Myer Squib. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Igor T. Gavrilovic, MD Dr. Gavrilovic has nothing to disclose.
Bruce A. C. Cree, MD, PhD, MCR, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. Dr. Cree has received publishing royalties from a publication relating to health care.
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Tara T. Lineweaver, MD Dr. Lineweaver has nothing to disclose.
Noah Rosen, MD, FAAN Dr. Rosen has received personal compensation for serving as an employee of Northwell Health. An immediate family member of Dr. Rosen has received personal compensation for serving as an employee of New York University. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen/ Novartis. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Speaker with American Headache Society.
Daniela Piani Meier Daniela Piani Meier has received personal compensation for serving as an employee of Novartis Pharma AG.
Mirla L. Avila, MD Dr. Avila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Genzyme, BMS, Serono. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen, genzyme, BMS. The institution of Dr. Avila has received research support from Texas Tech.
Alexander M. Papanastassiou Alexander M. Papanastassiou has received intellectual property interests from a discovery or technology relating to health care.
Shyam Prabhakaran, MD The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Jeffrey M. Burns, MD Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Renew Research. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris, Keplinger, Hicks and Welder. The institution of Dr. Burns has received research support from National Institutes of Health. The institution of Dr. Burns has received research support from Biogen. The institution of Dr. Burns has received research support from Eli Lilly. The institution of Dr. Burns has received research support from Amylyx. The institution of Dr. Burns has received research support from Abbvie. The institution of Dr. Burns has received research support from Astra-Zeneca.
Jin Li, MD, PhD, FAAN Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Li has a non-compensated relationship as a member, woman leadership committee with AAN that is relevant to AAN interests or activities.
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NexGen. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Toleranzia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Vivien H. Lee, MD, FAAN Dr. Lee has nothing to disclose.
Alla Shifrin, MD Dr. Shifrin has nothing to disclose.
Thomas J. Kaley, MD Dr. Kaley has received publishing royalties from a publication relating to health care.
Ronit Gilad Ms. Gilad has nothing to disclose.
Leonor Cabral-Lim, MD, FAAN Dr. Cabral-Lim has received personal compensation in the range of $0-$499 for serving as a Consultant for Hi-Eisai Pharmaceuticals Inc., Philippines . Dr. Cabral-Lim has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Hi-Eisai Pharmaceutical Inc., Philippines . Dr. Cabral-Lim has received research support from UCB BIOPHARMA SPRL . Dr. Cabral-Lim has received personal compensation in the range of $500-$4,999 for serving as a Member, Philippine Council for Mental Health with Department of Health,Philippines .
Katerina Tanya Perez Gosiengfiao No disclosure on file
Anne Caroline Papeix No disclosure on file
Sandrine Wiertlewski No disclosure on file
Benjamin L. Walter, MD Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Walter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott.
Darin T. Okuda, MD, FAAN Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RVL Pharmaceuticals, Inc.. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas BioPharma. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from EMD Serono. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Erin M. Dunbar, MD Dr. Dunbar has nothing to disclose.
Spozhmy Panezai, MD Dr. Panezai has nothing to disclose.
Rebecca F. Gottesman, MD Dr. Gottesman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Gottesman has received research support from NIH.
Koby Mok, PhD Dr. Mok has received personal compensation for serving as an employee of TG Therapeutics. Dr. Mok has received stock or an ownership interest from TG Therapeutics.
Alessandro Serra, MD Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
William C. Nichols, PhD No disclosure on file
Emmanuelle Le Page Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Kelly D. Foote, MD Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
Jason Lamar Aldred, MD, FAAN Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Boston Scientific. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Abbvie. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan . Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quadralynx. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Allergan. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for TEVA. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medtronic. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for US World Meds. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Arete Neuroscience, PLLC. The institution of Dr. Aldred has received research support from Biogen . The institution of Dr. Aldred has received research support from Abbvie. The institution of Dr. Aldred has received research support from Atara. The institution of Dr. Aldred has received research support from Takeda. The institution of Dr. Aldred has received research support from Merz. The institution of Dr. Aldred has received research support from AstraZeneca. The institution of Dr. Aldred has received research support from Neurocrine. The institution of Dr. Aldred has received research support from Aptinyx. The institution of Dr. Aldred has received research support from Cerevance. The institution of Dr. Aldred has received research support from Boston Scientific . The institution of Dr. Aldred has received research support from Parkinson Foundation . The institution of Dr. Aldred has received research support from Roche. The institution of Dr. Aldred has received research support from Theravance. The institution of Dr. Aldred has received research support from Triplet Therapeutics. The institution of Dr. Aldred has received research support from UCB. The institution of Dr. Aldred has received research support from Cerevel . The institution of Dr. Aldred has received research support from Sage Therapeutics. The institution of Dr. Aldred has received research support from Annovis. The institution of Dr. Aldred has received research support from Biovie. The institution of Dr. Aldred has received research support from Athira. The institution of Dr. Aldred has received research support from IRL. The institution of Dr. Aldred has received research support from NeuroDerm.
Mustafa S. Siddiqui, MD, FAAN Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. Dr. Siddiqui has received research support from Michael J. Fox Foundation. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from Sumaira Foundation for NMO. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory.
Rami Burstein, PhD Dr. Burstein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan. Dr. Burstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Burstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Burstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Burstein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Burstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dr. Reddy. Dr. Burstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Burstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Burstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Percept. Dr. Burstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Burstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theranica. The institution of Dr. Burstein has received research support from Allergan. The institution of Dr. Burstein has received research support from Teva. The institution of Dr. Burstein has received research support from Eli Lilly. The institution of Dr. Burstein has received research support from Dr. Reddy.
May Han, MD Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals.
Eric Klawiter, MD, FAAN Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Omer Faruk Turan, MD Dr. Turan has nothing to disclose.
Joshua Bonkowsky, MD, PhD Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Passage Bio. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bonkowsky has stock in Orchard. The institution of Dr. Bonkowsky has received research support from NIH. The institution of Dr. Bonkowsky has received research support from ELA. An immediate family member of Dr. Bonkowsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care.
John C. McHugh, MD, MBBS Dr. McHugh has nothing to disclose.
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Francoise Durand Dubief The institution of Francoise Durand Dubief has received research support from ARSEP.
Danielle Englert, MD Dr. Englert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific. Dr. Englert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. Dr. Englert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Englert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for adamas. Dr. Englert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acadia.
Codrin I. Lungu, MD, FAAN Dr. Lungu has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, inc..
M. Scott Perry, MD Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for stoke therapeutics. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded Therapeutics. Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Biosciences. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Zogenix. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW Biosciences.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Motric Bio.
Sarah E. Vollbracht, MD Dr. Vollbracht has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Vollbracht has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan.
David H. Salat David H. Salat has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuroimage. David H. Salat has received stock or an ownership interest from Niji. David H. Salat has received stock or an ownership interest from Smart Ion. The institution of David H. Salat has received research support from Renew.
Andrew R. Sas, MD, PhD Dr. Sas has nothing to disclose.
Julie E. Buring Julie E. Buring has nothing to disclose.
Maarten Jan Titulaer, MD, PhD The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from UpToDate Inc.
Robyn Busch Robyn Busch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Robyn Busch has received research support from NIH.
Adam Loavenbruck, MD Dr. Loavenbruck has nothing to disclose.
Deren Huang, MD Dr. Huang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Huang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech.
William Bingaman William Bingaman has nothing to disclose.
Tian Wang, MD Dr. Wang has nothing to disclose.
Marina Romano Marina Romano has nothing to disclose.
Christian Habeck Christian Habeck has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alzheimer's Prevention and Therapy Foundation. The institution of Christian Habeck has received research support from National Insitutes of Health.
Jay Shils No disclosure on file
Eli Diamond, MD Dr. Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Biopharmaceuticals. Dr. Diamond has received research support from Applebaum Foundation. Dr. Diamond has received research support from Frame Family Fund. Dr. Diamond has received research support from Joy Family West Foundation.
Ahsan Moosa Naduvil Valappil, MD Dr. Naduvil Valappil has nothing to disclose.
Elena Pentsova, MD The institution of Dr. Pentsova has received research support from YmAbs Therapeutics, Inc.
Nirali Vora, MD Dr. Vora has nothing to disclose.
Shnehal Patel, MD Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine.
Nathalie Derache Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS.
John Elliott John Elliott has nothing to disclose.
Jennifer Haut Jennifer Haut has nothing to disclose.
Jonathan Jagid Jonathan Jagid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic Inc. The institution of Jonathan Jagid has received research support from Boston Scientific. The institution of Jonathan Jagid has received research support from Medtronic Inc.
Michael Kurnellas Michael Kurnellas has received personal compensation for serving as an employee of Alector. Michael Kurnellas has received stock or an ownership interest from Alector. Michael Kurnellas has received intellectual property interests from a discovery or technology relating to health care.
Joseph Shrader Joseph Shrader has nothing to disclose.
Yuqing Zhang No disclosure on file
Murat Terzi, PhD Dr. Terzi has nothing to disclose.
Husnu Efendi, MD The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alexion. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Roche. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Novartis.
Iris Katharina Penner, PhD The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. The institution of Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene . Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Alexandra M. Miller, MD Dr. Miller has nothing to disclose.
Glenn Morrison, PhD Dr. Morrison has received personal compensation for serving as an employee of Alector. Dr. Morrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG . Dr. Morrison has received stock or an ownership interest from Alector. Dr. Morrison has received intellectual property interests from a discovery or technology relating to health care.
Amy K. Guzik, MD, FAAN Dr. Guzik has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local law firms, available by request.
Sara Khan, MD Dr. Khan has nothing to disclose.
Danish Bhatti, MD, FAAN Dr. Bhatti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Bhatti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Bhatti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accorda. Dr. Bhatti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Bhatti has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Accadia.
Christopher Coffey, PhD, FAAN Dr. Coffey has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Coffey has received research support from NIH. The institution of Dr. Coffey has received research support from Michael J Fox Foundation.
Roshini Jain Roshini Jain has received personal compensation for serving as an employee of Boston Scientific. Roshini Jain has received stock or an ownership interest from Boston Scientific.
Gian D. Pal, MD Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CLRM Law. Dr. Pal has stock in Baudax Bio. The institution of Dr. Pal has received research support from National Institutes of Health. The institution of Dr. Pal has received research support from Parkinson's Foundation. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with RKV Firm.
Peiqing Qian, MD Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS.
Derrick Robertson, MD Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parabon Nanolabs. The institution of Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Horizon Therapeutics. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Christopher Grunseich, MD Dr. Grunseich has nothing to disclose.
Maia Gomez Schneider No disclosure on file
Dustin A. Heldman, PhD Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.
Julie Pilitsis Julie Pilitsis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aim Medical Robotics . Julie Pilitsis has stock in Aim Medical Robotics . The institution of Julie Pilitsis has received research support from Medtronic. The institution of Julie Pilitsis has received research support from Boston Scientific. The institution of Julie Pilitsis has received research support from Abbott. The institution of Julie Pilitsis has received research support from NIH 2R01CA166379-06. The institution of Julie Pilitsis has received research support from NIH U44NS115111. Julie Pilitsis has received research support from NIH R01EB030324. Julie Pilitsis has received research support from NIH Blueprint 3U54EB015408.
Raul J. Rodriguez No disclosure on file
Kamakshi A. Patel, MD, FAAN Dr. Patel has nothing to disclose.
Corneliu C. Luca, MD Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health.
Marianna Shnayderman Yugrakh, MD The institution of Dr. Yugrakh has received research support from Teva.
Daniela Raffaela Galluzzo, MD Dr. Galluzzo has nothing to disclose.
Jennifer Lyn Durphy, MD Dr. Durphy has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acorda.
Josef Coresh Dr. Coresh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Healthy.io. The institution of Dr. Coresh has received research support from National Institute of Health.
Maria Cecilia Fernandez, MD Dr. Fernandez has nothing to disclose.
Sally Dunaway, DPT Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scholar Rock. Dr. Dunaway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cure SMA. The institution of Dr. Dunaway has received research support from Cure SMA. The institution of Dr. Dunaway has received research support from Scholar Rock. The institution of Dr. Dunaway has received research support from Ionis Pharmaceuticals.
Yian Gu, PhD The institution of Dr. Gu has received research support from NIH.
Chen Hoffmann Chen Hoffmann has nothing to disclose.
Pamela M. Rist, PhD The institution of Dr. Rist has received research support from National Institutes of Health. The institution of Dr. Rist has received research support from Brigham and Women's Hospital.
William D. Arnold, MD Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Roy E. Strowd, III, MD, FAAN Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Haralabos Zacharatos, MD Dr. Zacharatos has nothing to disclose.
Marcus Ng, MD The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Canada. Dr. Ng has received publishing royalties from a publication relating to health care.
Muhib Khan, MD, FAAN The institution of Dr. Khan has received research support from NINDS. The institution of Dr. Khan has received research support from Genentech. The institution of Dr. Khan has received research support from Spectrum Health-MSU alliance. Dr. Khan has received research support from NIH.
Juan Ramirez Castaneda, MD Dr. Ramirez Castaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Ramirez Castaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Dr. Ramirez Castaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ramirez Castaneda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Ramirez Castaneda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie .
Le Hua, MD, FAAN Dr. Hua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Hua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Hua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Hua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hua has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Hua has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapuetics. The institution of Dr. Hua has received research support from Biogen.
Ritesh Ramdhani, MD Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accorda. Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Ramdhani has received research support from NIH. Dr. Ramdhani has received research support from Parkinson Alliance.
Robert Paul, MD, PhD Dr. Paul has received personal compensation for serving as an employee of Alector. Dr. Paul has received stock or an ownership interest from Alector.
Roland Dominic Jamora Roland Dominic Jamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for torrent. Roland Dominic Jamora has received research support from CCXDP.
Regine Buffels, MD Dr. Buffels has nothing to disclose.
Andrew L. Lin, MD The institution of Dr. Lin has received research support from Bristol Myers Squibb. The institution of Dr. Lin has received research support from NantOmics. The institution of Dr. Lin has received research support from Society of Memorial Sloan Kettering Cancer Center.
Lila Emily Sheikhi, MD Dr. Sheikhi has nothing to disclose.
Mikael Cohen Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Tamir Ben Hur No disclosure on file
J. David Avila, MD Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB.
Jamie C. McDonald, MD Dr. McDonald has nothing to disclose.
Lydiane Mondot Lydiane Mondot has nothing to disclose.
Michael Pauciulo No disclosure on file
Rhea Angela M. Salonga, MD Dr. Salonga has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medichem . Dr. Salonga has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hi-Eisai . Dr. Salonga has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott . Dr. Salonga has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Torrent Philippines. Dr. Salonga has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Philippine League Against Epilepsy.
Jens Wuerfel, MD Dr. Wuerfel has received personal compensation for serving as an employee of MIAC AG. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Actelion. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Sean O'Dowd, MD Dr. O'Dowd has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axis Consulting.
James E. Siegler, III, MD Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various medicolegal cases. The institution of Dr. Siegler has received research support from Viz.ai.
Joel C. Geerling, MD, PhD No disclosure on file
Siddhart Kumar Mehta, MD Dr. Mehta has nothing to disclose.
Ajaz Sheikh, MD Dr. Sheikh has nothing to disclose.
Lauren Rhea Schaff, MD Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO. Dr. Schaff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BTG Pharmaceuticals. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. An immediate family member of Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MichieHamlett Attorneys at Law. The institution of Dr. Schaff has received research support from BTG, plc. The institution of Dr. Schaff has received research support from Merck. The institution of Dr. Schaff has received research support from DebioPharm.
Livia Almeida Dutra, MD Dr. Dutra Antonio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Dutra Antonio has received research support from Hospital Israelita Albert Einstein.
Hesham Ahmed Abboud, MD Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. Dr. Abboud has received publishing royalties from a publication relating to health care.
Aasef Shaikh, MD Dr. Shaikh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda.
Drew S. Kern, MD, FAAN Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Kern has received research support from Boston Scientific. The institution of Dr. Kern has received research support from AbbVie Pharmaceticals. Dr. Kern has received research support from Medtronic.
Michelle Fullard, MD Dr. Fullard has received research support from Davis Phinney Foundation. Dr. Fullard has received research support from Michael J. Fox Foundation. The institution of Dr. Fullard has received research support from NIH BIRCWH K12. Dr. Fullard has received research support from Lorna G. Moore Faculty Launch Fund.
Bertrand Bourre Bertrand Bourre has nothing to disclose.
Veronica A. Bruno, MD Dr. Bruno has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. The institution of Dr. Bruno has received research support from Paladin Labs. The institution of Dr. Bruno has received research support from Ipsen.
Daniel Corcos, PhD Daniel Corcos, PhD has nothing to disclose.
Fabian David No disclosure on file
María Del Carmen García No disclosure on file
Laura Negrotto Laura Negrotto has received personal compensation for serving as an employee of Merck. Laura Negrotto has received personal compensation in the range of $0-$499 for serving as a Consultant for Entelai.
Chahin Pachai Chahin Pachai has received personal compensation for serving as an employee of Bristol Myers Squibb. Chahin Pachai has stock in Bristol-Myers Squibb.
Lauren Doyle Strauss, DO Dr. Strauss has a non-compensated relationship as a Secretary with Southern Headache Society that is relevant to AAN interests or activities.
Yuan Cao Ms. Cao has nothing to disclose.
Shaida Khan, DO Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Chamblee Ryan .
Padmaja Sudhakar, MD Dr. Sudhakar has nothing to disclose.
Daniel L. Kenney-Jung, MD The institution of Dr. Kenney-Jung has received research support from CFC Foundation. The institution of Dr. Kenney-Jung has received research support from Advanced Medical Electronics/NIH. The institution of Dr. Kenney-Jung has received research support from Bluebird Bio. The institution of Dr. Kenney-Jung has received research support from Rare Disease Foundation.
Alexandra O'Neill Duffy, MD, FAAN Dr. Duffy has nothing to disclose.
Lei Liu, MD, PhD Dr. Liu has nothing to disclose.
Gabriel M. Moreno, MD Dr. Moreno has nothing to disclose.
Dixie Jean Ecklund, RN The institution of Ms. Ecklund has received research support from NIH. The institution of Ms. Ecklund has received research support from Michael J. Fox Foundation. Ms. Ecklund has received personal compensation in the range of $500-$4,999 for serving as a Scientific Review Board with Department of Defense. Ms. Ecklund has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Northwestern University.
Bart Van Wijmeersch, MD, PhD Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/Bristol Myers Group. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Pharmaceutics. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Prof. Van Wijmeersch has received research support from Merck. The institution of Prof. Van Wijmeersch has received research support from Roche.
Eric Thouvenot, MD, PhD Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biologix FZCo.. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HEALTHME. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.
Jonathan Ciron, MD Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS - Celgene. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Martin *Use 130037 Weber, MD Martin Weber, MD has nothing to disclose.
Davorka Tomic Davorka Tomic has stock in Meck KGaA.
Angeliki Vgontzas, MD Dr. Vgontzas has nothing to disclose.
William R. Renthal, MD No disclosure on file
Guadalupe Fernandez-Baca Vaca, MD Dr. Fernandez-Baca Vaca has nothing to disclose.
Katharine Alter, MD Katharine Alter, MD has received personal compensation for serving as an employee of Paradigm Medical Communications. Katharine Alter, MD has received personal compensation for serving as an employee of Cleveland clinic foundation. Katharine Alter, MD has received personal compensation for serving as an employee of Catalyst medical . Katharine Alter, MD has received personal compensation for serving as an employee of AANEM. Katharine Alter, MD has received personal compensation for serving as an employee of Efficiwent CME. Katharine Alter, MD has received publishing royalties from a publication relating to health care.
Sophie Arnould Sophie Arnould has nothing to disclose.
Michele Costigan, RN Ms. Costigan has nothing to disclose.
Alessandra Dellavance Alessandra Dellavance has nothing to disclose.
Robert Hoepner Robert Hoepner has nothing to disclose.
Jimena Miguez No disclosure on file
Celica Ysrraelit Celica Ysrraelit has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Celica Ysrraelit has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck, . Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bayer. Celica Ysrraelit has received research support from Novartis. The institution of Celica Ysrraelit has received research support from ROCHE. The institution of Celica Ysrraelit has received research support from Roche.
Ahmed Moh'd Yassin, MD Dr. Yassin has nothing to disclose.
Robin A. Buerki, MD, PhD No disclosure on file
Maria Pia Sormani Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Geneuro. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Xiangyi Meng, PhD Dr. Meng has nothing to disclose.
Ingo K. Mellinghoff, MD, FACP Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Agios. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Diamond Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Voyager Therapeutics . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kazia Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Diamond Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Group. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Puma Biotechnology. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DC Europa Ltd. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kazia Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardinal Health. Dr. Mellinghoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Mellinghoff has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ASCO/JCO. The institution of Dr. Mellinghoff has received research support from Amgen. The institution of Dr. Mellinghoff has received research support from General Electric. The institution of Dr. Mellinghoff has received research support from Lilly. The institution of Dr. Mellinghoff has received research support from Kazia Therapeutics. An immediate family member of Dr. Mellinghoff has received research support from Vigeo Therapeutics. The institution of an immediate family member of Dr. Mellinghoff has received research support from Samus Therapeutics. The institution of Dr. Mellinghoff has received research support from Erasca .
Krzysztof W. Selmaj Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Fabio Fieni Toso, MD Dr. Toso has nothing to disclose.
Nicholas James Fleming, MD Dr. Fleming has nothing to disclose.
Christopher M. McGraw, MD, PhD The institution of Dr. McGraw has received research support from NIH/NINDS. The institution of Dr. McGraw has received research support from Loulou Foundation. The institution of Dr. McGraw has received research support from CURE Epilepsy.
Mohammad Abu-Rub, MD Dr. Abu-Rub has nothing to disclose.
Mitra Afshari, MD The institution of Dr. Afshari has received research support from Consolidated Anti-Aging Foundation, Chicago, IL. The institution of Dr. Afshari has received research support from Rush University Department of Neurology.
Eliza Cushman Miller, MD Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for medical malpractice cases. The institution of Dr. Miller has received research support from National Institutes of Health. Dr. Miller has a non-compensated relationship as a member of ASA Advisory Council with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Christopher D. Geiger, MD Dr. Geiger has nothing to disclose.
Amy Nowacki Amy Nowacki has nothing to disclose.
Angela Kokkinis Angela Kokkinis has nothing to disclose.
Felippe Borlot, MD Dr. Borlot has nothing to disclose.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Justin Fraser The institution of Justin Fraser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Penumbra. The institution of Justin Fraser has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Justin Fraser has received personal compensation in the range of $0-$499 for serving as a Consultant for Stream Biomedical. Justin Fraser has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cerelux LLC. Justin Fraser has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Fawkes Biotechnology. Justin Fraser has received intellectual property interests from a discovery or technology relating to health care.
Maria Gaitan Maria Gaitan has received personal compensation in the range of $500-$4,999 for serving as a has received reimbursement for developing educational presentations and/or travel/accommodations stipends from with Merck SA, Merck-Serono Argentina, Biogen-Idec Argentina, Novartis Argentina, Roche Argentina,.
Mariela Cabrera Mariela Cabrera has nothing to disclose.
Tiffany K. Grider, MS, CGC Ms. Grider has received personal compensation in the range of $0-$499 for serving as a author of educational material with Muscle Dystrophy Association.
Lucia Derosa, MD Dr. Derosa has nothing to disclose.
David P. Bissig, MD Dr. Bissig has received personal compensation in the range of $100,000-$499,999 for serving as a Physician with University of California - Davis.
Michael Patrick Harlan Stanley, MD Dr. Stanley has received personal compensation for serving as an employee of Wall Street Journal. Dr. Stanley has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Content Producer with Roon. Dr. Stanley has a non-compensated relationship as a Content Creator with Neurobytes that is relevant to AAN interests or activities.
Elizabeth Coffee, MD Dr. Coffee has nothing to disclose.
Ch Hassin *use 311404 Ali No disclosure on file
Chintan K. Rupareliya, MD Dr. Rupareliya has nothing to disclose.
Galen Joe, 10561 Galen Joe, 10561 has nothing to disclose.
Dianalee McKnight, PhD Dr. McKnight has nothing to disclose.
Jose Leonard R Pascual Jose Leonard R Pascual has nothing to disclose.
Andrea L.C. Schneider, MD, PhD Dr. Schneider has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Neurology.
Farren Briggs, PhD The institution of Prof. Briggs has received research support from NIH. The institution of Prof. Briggs has received research support from Michael J. Fox Foundation.
Anirudh Sreekrishnan Dr. Sreekrishnan has nothing to disclose.
Celia Oreja Guevara Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for roche. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis.
Virginia DeLasHeras Virginia DeLasHeras has received personal compensation for serving as an employee of NOVARTIS.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation .
Alok Dabi, MD, MBBS Dr. Dabi has nothing to disclose.
Lily Lee, PhD Dr. Lee has nothing to disclose.
Tina Duong Tina Duong has received personal compensation for serving as an employee of Roche. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Scholar Rock. Tina Duong has received personal compensation for serving as an employee of Genentech. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Sarepta. Tina Duong has received personal compensation for serving as an employee of Biogen. Tina Duong has received personal compensation for serving as an employee of Audentes. Tina Duong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tina Duong has received personal compensation in the range of $0-$499 for serving as a Consultant for Audentes. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Tina Duong has received research support from biogen. The institution of Tina Duong has received research support from scholar rock.
Brian Walter, DO Dr. Walter has nothing to disclose.
Neda Sattarnezhad, MD Dr. Sattarnezhad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono. Dr. Sattarnezhad has received research support from National MS Society.
Subin Mathew, MD Dr. Mathew has nothing to disclose.
Smathorn Thakolwiboon, MD Dr. Thakolwiboon has nothing to disclose.
Nadav Bleich Kimelman Nadav Bleich Kimelman has nothing to disclose.
Uri Danon Uri Danon has received personal compensation for serving as an employee of Mapi Pharma Ltd..
kiran Erranki kiran Erranki has nothing to disclose.
Vibhor Krishna Vibhor Krishna has nothing to disclose.
Emily C. Martin Emily Martin has received personal compensation for serving as an employee of EMD Serono.
Shai Rubnov Shai Rubnov has received personal compensation for serving as an employee of Mapi pharma.
Cameron Mohammadi, MD Dr. Mohammadi has nothing to disclose.
Can Ebru Kurt, MD Can Ebru Kurt has nothing to disclose.
Marina Kushnirsky, MD Dr. Kushnirsky has nothing to disclose.
Giancarlo *USE ID 014384 Comi Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rewind.
Luiz Eduardo Andrade Luiz Eduardo Andrade has nothing to disclose.
Shyam Krishnakumar Jaiswal, MD, MBBS, DNB Dr. Jaiswal has nothing to disclose.
Farah Yolanda Fourcand, MD Dr. Fourcand has nothing to disclose.
Tyrell Jonathan Simkins, DO Dr. Simkins has nothing to disclose.
Yerasu Muralidhar Reddy, MD Dr. Muralidhar Reddy has nothing to disclose.
Abdullah Zahi Alqahtani, MD Dr. Alqahtani has nothing to disclose.
Omar Muhsin Ali Al-Janabi, MD, PhD, MS Dr. Al-Janabi has nothing to disclose.
Maria Ait Tihyaty, PhD Dr. Ait Tihyaty has received personal compensation for serving as an employee of Janssen.
Teresa Lee, MD Dr. Lee has nothing to disclose.
Aristide Merola, MD, PhD Dr. Merola has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Merola has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Merola has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Jessica Sanders, MD The institution of Dr. Sanders has received research support from Autism Intervention Research Network on Physical Health. The institution of Dr. Sanders has received research support from Accreditation Council for Graduate Medical Education.
Neel Fotedar, MD Dr. Fotedar has nothing to disclose.
Sepehr Sani Sepehr Sani has nothing to disclose.
Howard Sesso Howard Sesso has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Howard Sesso has received research support from Mars Edge. The institution of Howard Sesso has received research support from Pfizer Consumer Healthcare (now part of GSK Consumer Healthcare). The institution of Howard Sesso has received research support from Pure Encapsulations, Inc..
Adrian Isidoro Espiritu, MD Dr. Espiritu has nothing to disclose.
Shawna Huckell Miss Huckell has nothing to disclose.
Divya Rahul Shah, MBBS Dr. Shah has nothing to disclose.
Adriana Naomi Sari, MD Dr. Sari has nothing to disclose.
Zara Abigail Togher, MB BCh BAO Dr. Togher has nothing to disclose.
Lucia Jimena Zavala Ms. Zavala has nothing to disclose.
Petra Dirks Petra Dirks has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd .
Maria Eduarda Slhessarenko Maria Eduarda Slhessarenko has nothing to disclose.
Kyle R. Marden, MD Dr. Marden has nothing to disclose.
Maria Soledad Rodriguez Perez Mrs. Rodriguez Perez has nothing to disclose.
Huiam Mubarak, MD Dr. Mubarak has nothing to disclose.
Sajid Hameed Shaikh, MBBS, FCPS Dr. Shaikh has nothing to disclose.
Agustin Melo Carrillo, MD, PhD Dr. Melo Carrillo has nothing to disclose.
Rene De Araújo Gleizer, Jr., MD Dr. Gleizer has nothing to disclose.
Abdallah Omar Amireh, MD Dr. Amireh has nothing to disclose.
Mohamed Fahmy Doheim Mr. Doheim has nothing to disclose.
Mustafa Al-Chalabi, DO Dr. Al-Chalabi has nothing to disclose.
Faddi Ghassan M. Saleh Velez, MD Dr. Saleh Velez has nothing to disclose.
Evan Madill, MD The institution of Dr. Madill has received research support from American Academy of Neurology.
Kendall Nichols, MD Dr. Nichols has nothing to disclose.
Angela Aungst Angela Aungst has nothing to disclose.
Lilly Chen Lilly Chen has received personal compensation for serving as an employee of Boston Scientific .
Bruna De Freitas Dias, MD Bruna Dias has nothing to disclose.
Rafia Jawed, MD Dr. Jawed has nothing to disclose.
Clark Chen No disclosure on file
Steven Ojemann Steven Ojemann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Steven Ojemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager Therapeutics. The institution of Steven Ojemann has received research support from Voyager Therapeutics.
Aaron Hadley Aaron Hadley has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies.
Heather Kristin Martin, MD Heather Martin has nothing to disclose.
Nur *Use 170196 Yuceyar No disclosure on file
Janel Fedler, PhD Dr. Fedler has nothing to disclose.
Pawan Soni No disclosure on file
Laura Popper, MD Dr. Popper has received personal compensation for serving as an employee of Mapi Pharma.
Michael S. Weiss Michael S. Weiss has received personal compensation for serving as an employee of TG Therapeutics. Michael S. Weiss has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for TG Therapeutics. Michael S. Weiss has received stock or an ownership interest from TG Therapeutics.
Brian McAdams Brian McAdams has nothing to disclose.
Connie Wolford, NP Ms. Wolford has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Marina Vives-Mestres Marina Vives-Mestres has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Curelator. The institution of Marina Vives-Mestres has received research support from Ministerio de Ciencia, Innovación y Universidades; Ref: RTI2018-095518-B-C21.
Thomas Kuenzel Thomas Kunzel has received personal compensation for serving as an employee of Roche.
Zihuai He Zihuai He has nothing to disclose.
Dargelis Chi, MD Dr. Chi has nothing to disclose.
Romana Hoeftberger Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with Euroimmun, Biogen, Sanofi-Aventis, and UCB Biopharma.
Monica Sarkar, MD Dr. Sarkar has nothing to disclose.
Chandra Sekhar Mannyam, MBBS Dr. Mannyam has nothing to disclose.
Angela Pontius Mrs. Pontius has received personal compensation for serving as an employee of Vigil Neuroscience, Inc.
David Klements, MS Mr. Klements has nothing to disclose.
Miranda Munoz Miranda Munoz has nothing to disclose.
Michelle Anlacan Michelle Anlacan has received personal compensation in the range of $0-$499 for serving as a Consultant for Torrent Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medichem Philippines. Michelle Anlacan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hi Eisai Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natrapharm Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Alzheimer's disease association of the philippines. Michelle Anlacan has received research support from Philippine Council for Health Research and Development. Michelle Anlacan has received research support from Philippine Neurological Association.
Guadalupe Bruera Guadalupe Bruera has nothing to disclose.
Diego Silva Diego Silva has received personal compensation for serving as an employee of BMS. Diego Silva has received stock or an ownership interest from BMS.
Yarden Bornovski, MD Dr. Bornovski has nothing to disclose.
Yarema B Bezchlibnyk Yarema B Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PMT Corporation. Yarema B Bezchlibnyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Yarema B Bezchlibnyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Yarema B Bezchlibnyk has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic.
INTREPID Study Group INTREPID Study Group has received personal compensation for serving as an employee of Boston Scientific . INTREPID Study Group has received stock or an ownership interest from Boston Scientific .
Tejas Ranade, MD Dr. Ranade has nothing to disclose.
Nasar Ali, DO Dr. Ali has nothing to disclose.
Elham Abushanab, MD Dr. Abushanab has nothing to disclose.
Amy Li Safadi, MD Dr. Safadi has nothing to disclose.
Ch Hassan Ali, MD, MBBS Dr. Ali has nothing to disclose.
Teye Aniefiok Umanah, MD Dr. Umanah has nothing to disclose.
Alaa Ahmed Elshinbary, III, Ms Ms. Elshinbary has nothing to disclose.
Mostafa Mahmoud Meshref, MD Dr. Meshref has nothing to disclose.
Sydney Moseley, MD Dr. Moseley has nothing to disclose.
Kristina Maselli, MD Dr. Maselli has nothing to disclose.
Jenna Bosco Jenna Bosco has received personal compensation for serving as an employee of TG Therapeutics. Jenna Bosco has received stock or an ownership interest from TG Therapeutics.
Ronald Wapner Ronald Wapner has nothing to disclose.
Sean Power Sean Power has received personal compensation for serving as an employee of TG Therapeutics, Inc. Sean Power has received stock or an ownership interest from TG Therapuetics, Inc..
Ivan Staikov Ivan Staikov has received personal compensation in the range of $0-$499 for serving as a Consultant for Ewopharma-Biogen. Ivan Staikov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzime. Ivan Staikov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merch. Ivan Staikov has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medochemi. Ivan Staikov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Gedeon Richter. Ivan Staikov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Ivan Staikov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Ivan Staikov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Gerot Lannach. Ivan Staikov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Ivan Staikov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viatris. Ivan Staikov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Nobel Pharma. Ivan Staikov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Karolina Piasecka-Stryczynska Karolina Piasecka-Stryczynska has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Karolina Piasecka-Stryczynska has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Karolina Piasecka-Stryczynska has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Jennifer Merickel Jennifer Merickel has nothing to disclose.
Maria Justich Maria Justich has nothing to disclose.
Nikolai Gil Diwa Reyes, MD Dr. Reyes has nothing to disclose.
Muhammad Nagy, MBBCh, M.Sc Dr. Nagy has nothing to disclose.
James Simples, Jr., PhD Dr. Simples has stock in Janssen.
Jie Pan, MD Dr. Pan has nothing to disclose.
Arifa Ghori Dr. Ghori has nothing to disclose.
Vijaya Lakshmi Valaparla, MD Dr. Valaparla has nothing to disclose.
Alexander Lewis, DO Dr. Lewis has nothing to disclose.
Kaancan Deniz, MD Dr. Deniz has nothing to disclose.
Sidra Saleem, MD Dr. Saleem has nothing to disclose.
Mohamed Elkasaby, MD Dr. Elkasaby has nothing to disclose.
Rozena Davis, NP Mrs. Davis has nothing to disclose.
Sinead Murphy Sinead Murphy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Sinead Murphy has received research support from Novartis.
Elizabeth Anderson, MD Dr. Anderson has nothing to disclose.
Connor David Welsh, DO Dr. Welsh has nothing to disclose.
Roberto Hernandez Quintana, MD Dr. Hernandez Quintana has nothing to disclose.
Lalitha Pidaparthi, DM Dr. Lalitha has nothing to disclose.
Rui Tang Mr. Tang has nothing to disclose.
Graham Alexander McLeod, MD Dr. McLeod has nothing to disclose.
Holly Elser, MD, PhD Dr. Elser has nothing to disclose.
Brianne Lacy, MD Ms. Lacy has nothing to disclose.
Margo A. Peyton, MD Dr. Peyton has nothing to disclose.
Heather Lapidus Glassner Heather Lapidus Glassner has received personal compensation for serving as an employee of MyHealthTeams.
Navkiranjot Kaur Ms. Kaur has nothing to disclose.
Swaroop Aradhya Swaroop Aradhya has received personal compensation for serving as an employee of Invitae. An immediate family member of Swaroop Aradhya has received personal compensation for serving as an employee of Invitae. Swaroop Aradhya has received stock or an ownership interest from Invitae. An immediate family member of Swaroop Aradhya has received stock or an ownership interest from Invitae. The institution of Swaroop Aradhya has received research support from National Institutes of Health. An immediate family member of Swaroop Aradhya has received personal compensation in the range of $500-$4,999 for serving as a Science editor consultant with FHI360.
Sara Bristow Sara Bristow has received personal compensation for serving as an employee of Invitae. Sara Bristow has received stock or an ownership interest from Invitae.
Berin Inan Berin Inan has nothing to disclose.
Sevim *Use 395876 Ozdamar Sevim Ozdamar has nothing to disclose.
Marie Charmaine Cootauco Sy, MD Marie Charmaine Sy has nothing to disclose.
Madeline Williamson Madeline Williamson has nothing to disclose.
Amparo Casanova Amparo Casanova has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Curelator Inc..
Jiping Li Jiping Li has nothing to disclose.
Ana Morales Ana Morales has received personal compensation for serving as an employee of Invitae. Ana Morales has stock in Invitae.
Marc Laurence Fernandez Marc Laurence Fernandez has nothing to disclose.
Alexa Walter Alexa Walter has nothing to disclose.
Doruk Arslan, MD Dr. Arslan has nothing to disclose.
Michael Ward Michael Ward has received personal compensation for serving as an employee of Alector. Michael Ward has stock in Alector. Michael Ward has received intellectual property interests from a discovery or technology relating to health care. Michael Ward has a non-compensated relationship as a Reviewer with ADDF that is relevant to AAN interests or activities.
Tina Schwabe Tina Schwabe has received personal compensation for serving as an employee of Alector. An immediate family member of Tina Schwabe has received personal compensation for serving as an employee of Coda Biotherapeutics. Tina Schwabe has received stock or an ownership interest from Alector. An immediate family member of Tina Schwabe has received stock or an ownership interest from Coda Biotherapeutics. Tina Schwabe has received intellectual property interests from a discovery or technology relating to health care.
Ashley Whitmarsh Ashley Whitmarsh has nothing to disclose.
Rachel Graham Rachel Graham has nothing to disclose.
Jianyu LI Jianyu LI has nothing to disclose.
Amira Benmelouka Amira Benmelouka has nothing to disclose.
Lisa Ferguson Lisa Ferguson has nothing to disclose.
Ayan Das Gupta Ayan Das Gupta has received personal compensation for serving as an employee of Novartis Health Care Pvt. Ltd.
Carly Jo Olszewski Ms. Olszewski has nothing to disclose.
Abigail Zatkalik Abigail Zatkalik has nothing to disclose.
Rene Pierpont The institution of Rene Pierpont has received research support from Alexion Pharmaceuticals. The institution of Rene Pierpont has received research support from CFC International. The institution of Rene Pierpont has received research support from NIH. The institution of Rene Pierpont has received research support from Rare Disease Foundation.
Patricia Klaas Patricia Klaas has nothing to disclose.
Guang Tu Guang Tu has received personal compensation for serving as an employee of Alector. Guang Tu has received stock or an ownership interest from Alector.
Karen Kadner Karen Kadner has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd.
Ann Stowe Ann Stowe has received stock or an ownership interest from Cerelux LLC. The institution of Ann Stowe has received research support from NIH/NINDS. The institution of Ann Stowe has received research support from AHA. The institution of Ann Stowe has received research support from Craig H Neilsen Foundation. Ann Stowe has received intellectual property interests from a discovery or technology relating to health care. Ann Stowe has received personal compensation in the range of $500-$4,999 for serving as a grant reviewer with NIH.
Hans Guehring Hans Guehring has received personal compensation for serving as an employee of EMD Serono.
Jonathan Carlson Jonathan Carlson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for medtronic.
Hua Long Hua Long has received personal compensation for serving as an employee of Alector. Hua Long has received stock or an ownership interest from Alector. Hua Long has received intellectual property interests from a discovery or technology relating to health care.
Dee Stoneman Dee Stoneman has received personal compensation for serving as an employee of Novartis.
Kristina Holmberg, PhD Dr. Holmberg has received stock or an ownership interest from Merck KGaA.
Rushna Ali, MD Dr. Ali has nothing to disclose.
Supreeth Gowda Narayana Gowda, MBBS Dr. Gowda has nothing to disclose.
Camilo Obando Dr. Obando has received personal compensation for serving as an employee of Johnson & Johnson. An immediate family member of Dr. Obando has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Obando has stock in Johnson & Johnson. An immediate family member of Dr. Obando has stock in Johnson & Johnson.
Carolina Laura Azcona, MD Dr. Azcona has nothing to disclose.
Luke Skyler Vest Mr. Vest has nothing to disclose.
Mohammed Qussay Ali Al-Sabbagh, MD Dr. Al-Sabbagh has nothing to disclose.
Camille Barbour, MD No disclosure on file
Benton Maglinger, MD Mr. Maglinger has nothing to disclose.
Mikul Minesh Bhikha Mr. Bhikha has nothing to disclose.
Joshual Emmanuel Abejero JOSHUA EMMANUEL ABEJERO has nothing to disclose.
Moriah Mabry Ms. Mabry has nothing to disclose.
Xiaoyan Huang Ms. Huang has nothing to disclose.
Ari Vandersluis, DO Mr. Vandersluis has nothing to disclose.
Mohamed Sayed Zaazouee Mr. Zaazouee has nothing to disclose.
Rajeet Shrestha Dr. Shrestha has nothing to disclose.
Morgan Maley, Other Ms. Maley has nothing to disclose.
Jill Winegardner, PhD Dr. Winegardner has nothing to disclose.
Tammy Rogers, RN Mrs. Rogers has nothing to disclose.
Ibrahim Turkoz, PhD Dr. Turkoz has received personal compensation for serving as an employee of Janssen R&D. Dr. Turkoz has received stock or an ownership interest from J&J.
Tom Mosley, Jr., PhD The institution of Dr. Mosley has received research support from NIH.
Alexander Paul Ambrosini Mr. Ambrosini has nothing to disclose.
Gular Mammadli, MD Dr. Mammadli has nothing to disclose.
Rebecca Merrill Ms. Merrill has nothing to disclose.
Kevin Alexander Soltany Mr. Soltany has received personal compensation for serving as an employee of Alliance for Health Policy. Mr. Soltany has received personal compensation in the range of $0-$499 for serving as a Consultant for Health Affairs.
Emily Fishman Ms. Fishman has nothing to disclose.
Rebecca Siobhan-Ivy Cox, Other Ms. Cox has nothing to disclose.
Kelly Ann Pring Ms. Pring has nothing to disclose.
Sharon Thomson, Other Miss Thomson has nothing to disclose.
Cassandre Landes-Chateau, PhD Mrs. Landes-Chateau has received research support from University Cote d'Azur.
Jun Ha Chang, PhD Dr. Chang has nothing to disclose.
Gabriella Marie Bognet, Other Ms. Bognet has nothing to disclose.
Paul Hart, MD Dr. Hart has nothing to disclose.
Suhang Song, PhD Dr. Song has nothing to disclose.
Wendy Su Prof. Su has received personal compensation for serving as an employee of Novartis. Prof. Su has received stock or an ownership interest from Novartis.
Ronald Zielman Dr. Zielman has received personal compensation for serving as an employee of Novartis.
Skyler Rosen, Other Mr. Rosen has nothing to disclose.
Khaled Mohamed Ragab, MD Dr. Ragab has nothing to disclose.
Dana McDonnell, Other Miss McDonnell has nothing to disclose.
Xavier Puig Dr. Puig has nothing to disclose.
Natalie Ann Bello, MD Dr. Bello has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. The institution of Dr. Bello has received research support from NIH.
Mary E. D'Alton, MD Dr. D'Alton has a non-compensated relationship as a Advisory Board with Merck for Mothers that is relevant to AAN interests or activities.
Dante James Rogers Mr. Rogers has nothing to disclose.
Cynthia Gyamfi-Bannerman, MD Dr. Gyamfi-Bannerman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hologic. Dr. Gyamfi-Bannerman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medela. Dr. Gyamfi-Bannerman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CGB Science.
Edward Kim, MD Dr. Kim has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Kim has stock in Biohaven Pharmaceuticals.
Muralikrishna Konda, MD, MBBS, MRCP Dr. Konda has nothing to disclose.
William Grobman, MD Dr. Grobman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABOG. Dr. Grobman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Grobman has received research support from NIH.
David M. Haas, MD The institution of Dr. Haas has received research support from NIH.
Lisa Levine, MD Dr. Levine has nothing to disclose.
Sue Zann Gan, MBBS Dr. Gan has nothing to disclose.
Sharon Scarbro Ms. Scarbro has nothing to disclose.
Dong-Hui Ao Dr. Ao has nothing to disclose.
Muhammed Kilinc, IV, PhD Mr. Kilinc has nothing to disclose.
John Matthew Garza, PhD Dr. Garza has nothing to disclose.
Fatma Mohamed Sayed Dr. Sayed has nothing to disclose.
Elfatih A. Hasabo, MBBS Dr. Hasabo has nothing to disclose.
Ghada Said Hammad, Other Miss Hammad has nothing to disclose.
Jessica *Use 389572 Cirillo, Other Mrs. Cirillo has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Mrs. Cirillo has received stock or an ownership interest from Biohaven Pharmaceuticals.
Jingxiao Zhang Dr. Zhang has nothing to disclose.
Abhinay Kumar Gattu, Jr. Mr. Gattu has nothing to disclose.
Sindhuja Ayyagari Ms. Ayyagari has nothing to disclose.
Mingyan Guo, MD,PhD Dr. Guo has nothing to disclose.
Hallie Harris Miss Harris has nothing to disclose.
Dana Katherine Mitchell, Other Miss MITCHELL has nothing to disclose.
Sherouk Shawkat Moham Elkady, MBBS Dr. Elkady has nothing to disclose.
Xixi Hu Ms. Hu has received personal compensation for serving as an employee of Novartis.
Kristi Chau, Other Ms. Chau has nothing to disclose.
Madelyn Kay Smiley Miss Smiley has nothing to disclose.
Monica Doring Ms. Doring has received stock or an ownership interest from Johnson & Johnson.
P Anusha, Jr., Other Mrs. Anusha has nothing to disclose.
Yijie Liao, PhD Dr. Liao has received personal compensation for serving as an employee of Alector. Dr. Liao has received stock or an ownership interest from Alector.
Viviana Andrea Ibarra, MD Dr. Ibarra has nothing to disclose.
Amanda L. Trout, PhD,NP Dr. Trout has nothing to disclose.
Jeff Maca, PhD Mr. Maca has nothing to disclose.
Christopher McLouth, PhD Dr. McLouth has nothing to disclose.
Keith Pennypacker, PhD Prof. Pennypacker has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal Of Neuroinflammation. The institution of Prof. Pennypacker has received research support from NIH. Prof. Pennypacker has received intellectual property interests from a discovery or technology relating to health care.
Chun-Yen Cheng, Other Mr. Cheng has received personal compensation for serving as an employee of Bristol Myers Squibb. Mr. Cheng has stock in Bristol Myers Squibb.
Jadwiga Turchan, PhD Dr. Turchan has nothing to disclose.
Samuel Kroening Mr. Kroening has nothing to disclose.
Sidra Zaheer, MD Dr. Zaheer has nothing to disclose.
Madison Sands Ms. Sands has nothing to disclose.
Nivedita Jha, MD, MBBS Dr. Jha has nothing to disclose.
Mohammed Bassam Nawaiseh, MD Dr. Nawaiseh has nothing to disclose.
Mengyi Xu Miss Xu has received personal compensation for serving as an employee of Brigham and Women's Hospital.
Edward D. Esplin, MD,PhD Dr. Esplin has received personal compensation for serving as an employee of Invitae. Dr. Esplin has received stock or an ownership interest from Invitae.
Darion Toutant Mr. Toutant has nothing to disclose.
Whitney Tang Mrs. Tang has nothing to disclose.
Enrique Ivan Ramos, PhD Dr. Ramos has received research support from Endocrine Society. Dr. Ramos has received research support from American Association for Cancer Research.
Ravi Nulaka, Jr., Other Mr. Nulaka has nothing to disclose.
Jing Xi, PhD Dr. Xi has received personal compensation for serving as an employee of Novartis.
Jacqueline A. Frank, Other Mrs. Frank has nothing to disclose.
Whitney Alexandra Booker, MD Dr. Booker has nothing to disclose.
Chad Eric Grueter, PhD The institution of Dr. Grueter has received research support from NIH.
Ryan O'Mara, Other Mr. O'Mara has received personal compensation for serving as an employee of VIgil Neuroscience, LLC.
Amy Roberts, MD Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Tanoury, Nauts, McKinney & Dwaihy, PLLC. The institution of Dr. Roberts has received research support from NIH.
David Jason McCracken, MD Dr. McCracken has received personal compensation for serving as an employee of GT Medical. Dr. McCracken has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical. Dr. McCracken has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GT Medical.
Kathryn Hatchell, PhD Dr. Hatchell has received personal compensation for serving as an employee of Invitae.
Chad Moretz, PhD Dr. Moretz has received personal compensation for serving as an employee of Invitae. Dr. Moretz has received stock or an ownership interest from Invitae.
Parandoush Abbasian, Other Ms. Abbasian has nothing to disclose.
Rupesh Kotecha, MD Dr. Kotecha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accuray Inc.. Dr. Kotecha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Elekta AB. Dr. Kotecha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure Inc.. Dr. Kotecha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viewray Inc. Dr. Kotecha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainlab. Dr. Kotecha has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure Inc. Dr. Kotecha has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Practice Update.
Felix Leejia Yeh, PhD Dr. Yeh has received stock or an ownership interest from Alector. Dr. Yeh has received stock or an ownership interest from Genentech. Dr. Yeh has received personal compensation in the range of $100,000-$499,999 for serving as a Scientist with Genentech. Dr. Yeh has received personal compensation in the range of $100,000-$499,999 for serving as a Head of Biomarkers with Alector.
Josep Ginebra, PhD Mr. Ginebra has nothing to disclose.
David Dornbos, III, MD Dr. Dornbos has received personal compensation in the range of $0-$499 for serving as a Consultant for Imperative Care. Dr. Dornbos has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nico Corporation. The institution of Dr. Dornbos has received research support from Siemens.
Ahmad Al Nawaiseh, MD Dr. Al Nawaiseh has nothing to disclose.
Bharathi Gadad, PhD Dr. Gadad has nothing to disclose.
Tina Schwabe, PhD Dr. Schwabe has received personal compensation for serving as an employee of Alector. Dr. Schwabe has received personal compensation for serving as an employee of Nine Square Therapeutics. Dr. Schwabe has received stock or an ownership interest from Alector. Dr. Schwabe has received intellectual property interests from a discovery or technology relating to health care.
Julie Huang, PhD Dr. Huang has received personal compensation for serving as an employee of Alector, Inc. Dr. Huang has stock in Alector.
Amber Silva Mrs. Silva has nothing to disclose.
Jenna Pappalardo, PhD Dr. Pappalardo has received personal compensation for serving as an employee of Alector. An immediate family member of Dr. Pappalardo has received personal compensation for serving as an employee of Arcus Biosciences. Dr. Pappalardo has received stock or an ownership interest from Alector. An immediate family member of Dr. Pappalardo has received stock or an ownership interest from Arcus Biosciences. An immediate family member of Dr. Pappalardo has received intellectual property interests from a discovery or technology relating to health care.
Herve Rhinn, PhD Dr. RHINN has received personal compensation for serving as an employee of Alector. Dr. RHINN has received stock or an ownership interest from Alector. Dr. RHINN has received stock or an ownership interest from Prevail. Dr. RHINN has received intellectual property interests from a discovery or technology relating to health care. Dr. RHINN has received intellectual property interests from a discovery or technology relating to health care. Dr. RHINN has received intellectual property interests from a discovery or technology relating to health care.
Anna Rychkova, PhD Dr. Rychkova has received personal compensation for serving as an employee of Alector. Dr. Rychkova has received stock or an ownership interest from Alector.
Patrick M. Moriarty, MD Dr. Moriarty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Moriarty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esperion. Dr. Moriarty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kaneka. Dr. Moriarty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Moriarty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stage II Innovation/ Renew Research. Dr. Moriarty has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Esperion. Dr. Moriarty has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Moriarty has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Regeneron. The institution of Dr. Moriarty has received research support from Amgen. The institution of Dr. Moriarty has received research support from FHFoundation. The institution of Dr. Moriarty has received research support from GB Life Sciences. The institution of Dr. Moriarty has received research support from Ionis. The institution of Dr. Moriarty has received research support from Kaneka. The institution of Dr. Moriarty has received research support from Novartis. The institution of Dr. Moriarty has received research support from Regeneron. The institution of Dr. Moriarty has received research support from Stage II Innovation/ Renew Research. The institution of Dr. Moriarty has received research support from Esperion.
Adam Wayne Nowlan, MD Dr. Nowlan has received personal compensation for serving as an employee of GT Medical. Dr. Nowlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical.
Kenneth Stuart Lee, MD Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GT Medical. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Huff Powell Bailey Law Firm. An immediate family member of Dr. Lee has stock in Remedy Pharmaceuticals. An immediate family member of Dr. Lee has stock in Martin Pharmaceuticals. An immediate family member of Dr. Lee has stock in Critical Diagnostics. An immediate family member of Dr. Lee has stock in Woolsey Pharmaceuticals. An immediate family member of Dr. Lee has stock in Monogram Orthopaedics. An immediate family member of Dr. Lee has stock in Cytonics. An immediate family member of Dr. Lee has stock in 20-20 Gene Systems.
Cheryl Barner Ms. Barner has nothing to disclose.
Sam Jackson, MD,Other Dr. Jackson has received personal compensation for serving as an employee of Alector . Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Headland Strategy. Dr. Jackson has stock in Alector and other companies engaged in the business of drug development. .
Daniel Maslyar, MD Dr. Maslyar has received personal compensation for serving as an employee of Alector. Dr. Maslyar has stock in Alector.
Peter Thompson, MD The institution of Dr. Thompson has received research support from McKee Foundatioin.
Katerina Tanya *USE ID 113126 Gosiengfiao, MD Dr. Gosiengfiao has received personal compensation in the range of $0-$499 for serving as a Consultant for Hi Esai Pharmaceuticals. Dr. Gosiengfiao has received personal compensation in the range of $0-$499 for serving as a Consultant for Torrent Pharmaceuticals. Dr. Gosiengfiao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hi Esai. Dr. Gosiengfiao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Torrent Pharmaceuticals. Dr. Gosiengfiao has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbott. Dr. Gosiengfiao has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medichem Pharmaceuticals. Dr. Gosiengfiao has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sun Pharmaceuticals. Dr. Gosiengfiao has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Philippine League Against Epilepsy. Dr. Gosiengfiao has received stock or an ownership interest from Martessem. Dr. Gosiengfiao has received stock or an ownership interest from VCI. An immediate family member of Dr. Gosiengfiao has received stock or an ownership interest from Northwestern Eye Center. An immediate family member of Dr. Gosiengfiao has received stock or an ownership interest from VCI. An immediate family member of Dr. Gosiengfiao has received stock or an ownership interest from FTB Anunas. Dr. Gosiengfiao has received personal compensation in the range of $500-$4,999 for serving as a Moderator, Lecturer, Organizing/Scientific Committee member with Philippine League Against Epilepsy.
Toral R. Patel, MD Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Elekta. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Elekta. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GT Medical Technologies. An immediate family member of Dr. Patel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mann Morrow, PLLC. The institution of Dr. Patel has received research support from NINDS. The institution of Dr. Patel has received research support from NIH/NCI. The institution of Dr. Patel has received research support from CPRIT. The institution of Dr. Patel has received research support from NIH/NCI. The institution of Dr. Patel has received research support from Ben and Catherine Ivy Foundation. Dr. Patel has received intellectual property interests from a discovery or technology relating to health care.
Jane Green, Other Ms. Green has nothing to disclose.
Hien Piotrowski Mr. Piotrowski has nothing to disclose.
Mustafa Husain, MD Dr. HUSAIN has nothing to disclose.
Thomas Moreno Mr. Moreno has received personal compensation for serving as an employee of Renew Research.
Jerson Flores Agabao, MD Dr. Agabao has nothing to disclose.
Mitesh Shah, MD Dr. Shah has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker.
Emmanuel Ang Mr. Ang has nothing to disclose.
Maziar Fazel Darbandi Mr. Fazel Darbandi has nothing to disclose.
Charles D. Thompson, MD Dr. Thompson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Erica Hennigs, PA Ms. Hennigs has nothing to disclose.
Yunglin Gazes, PhD Dr. Gazes has nothing to disclose.
Seonjoo Lee, PhD Dr. Lee has received personal compensation for serving as an employee of New York State Psychiatric Institute.
Matthew Brennan, Other Mr. Brennan has received personal compensation for serving as an employee of Vigil Neuroscience.
Javier Vargas Medrano, PhD Dr. Vargas Medrano has nothing to disclose.
Erica Sanes, Other Ms. Sanes has nothing to disclose.
John Wanebo, MD Dr. Wanebo has received stock or an ownership interest from Gamma TIle.
Chao Ma Dr. Ma has nothing to disclose.
Wen-Ying Qiu Dr. Qiu has nothing to disclose.
David Brachman, MD Dr. Brachman has received personal compensation for serving as an employee of GT Medical Technologies. Dr. Brachman has stock in GT Medical Technologies.
Lauryn K. Gorby Ms. Gorby has nothing to disclose.
Santiago Viveros Salazar, PhD Dr. Salazar has received stock or an ownership interest from Alector. Dr. Salazar has received intellectual property interests from a discovery or technology relating to health care.
Ilaria Tassi, PhD Dr. Tassi has nothing to disclose.
Manar Mohammed Hosny Mrs. Hosny has nothing to disclose.
Tricia Y. Ting, MD Dr. Ting has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB.
David Weintraub, MD Dr. Weintraub has nothing to disclose.
Martin Zenker, MD Prof. Zenker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Prof. Zenker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Prof. Zenker has received research support from German Ministry of Education and Research (BMBF). The institution of Prof. Zenker has received research support from German Research Foundation (DFG).
Anas Zakarya Nourelden, Jr., MD Dr. Nourelden has nothing to disclose.
Jonathan Helfgott Mr. Helfgott has nothing to disclose.
Jaclyn Klepper, PhD Dr. Klepper has nothing to disclose.
Mariam Abdelwhaab Asela, MD No disclosure on file
Zabi Wardak, MD Dr. Wardak has nothing to disclose.
Kenn Alan Freedman, MD Dr. Freedman has nothing to disclose.
Ilya Dubinsky, Other Dr. Dubinsky has nothing to disclose.
Catherine Lee, PhD Dr. Lee has nothing to disclose.
John Robert Floyd, II, MD Dr. Floyd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Technology .
Loreto Rios-Pohl, MD Dr. Rios-Pohl has nothing to disclose.
Shivani Pahwa, MD Dr. Pahwa has nothing to disclose.
Brittany Lipinski Mrs. Lipinski has received personal compensation for serving as an employee of Delray Center for Recovery.
Cara Harbaugh, Other Miss Harbaugh has nothing to disclose.
Nimar Kahlon, MD Dr. Kahlon has nothing to disclose.
Michael William McDermott, MD Dr. McDermott has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. McDermott has stock in Zap Surgical . Dr. McDermott has stock in Deinde Medical. The institution of Dr. McDermott has received research support from State of Florida . Dr. McDermott has received intellectual property interests from a discovery or technology relating to health care.
David Monyak, MD Dr. Monyak has nothing to disclose.
Kaitlin Angione No disclosure on file
Lacey Burkett No disclosure on file
Kathryn Dusenbery Kathryn Dusenbery has nothing to disclose.
Amirhossein Ghassemi No disclosure on file
Cynthia Griggins No disclosure on file
Philip Hale No disclosure on file
Sara Mohamed Hasan No disclosure on file
Amal Abdelfattah Mahmoud No disclosure on file
Leslie Moroz No disclosure on file
Alan Peiris No disclosure on file